Save your place

Sign in to WhoBought

Please try again later.

Castle Biosciences, Inc. (CSTL) institutional ownership

Latest close $24.81 Jul 22, 2026
Market cap$589M 52-week range SectorHealthcare
Funds holding · Q1 2026
189
reported CSTL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
94 buyers · 95 sellers

Castle Biosciences, Inc. (CSTL) price and institutional activity

Dates

Q1 2026

$0 bought by 94 investors
Rtw Investments, LPQube Research & Technologies Ltd +92 more
$0 sold by 95 investors
Portolan Capital Management, LLCCitadel Advisors LLC +93 more
Bought Sold Totals per quarter; hover a bar for the names.

Castle Biosciences, Inc. (CSTL) institutional activity · 189

Investor Type Est. change Change Δ Own Date
Rtw Investments, LP · Added
Change +643K Date Q1 2026
Rtw Investments, LP Added· Q1 2026 +643K Q1 2026
Portolan Capital Management, LLC · Reduced
Change −379K Date Q1 2026
Portolan Capital Management, LLC Reduced· Q1 2026 −379K Q1 2026
Qube Research & Technologies Ltd · Added
Change +324K Date Q1 2026
Qube Research & Technologies Ltd Added· Q1 2026 +324K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −245K −67.0% Q1 2026
Morgan Stanley · Added
Change +225K Date Q1 2026
Morgan Stanley Added· Q1 2026 +225K Q1 2026
SG Americas Securities, LLC · Added
Change +224K Date Q1 2026
SG Americas Securities, LLC Added· Q1 2026 +224K Q1 2026
Wellington Management Group LLP · Exited
Change −219K Δ Own −100.0% Date Q1 2026
Wellington Management Group LLP Exited· Q1 2026 −219K −100.0% Q1 2026
Bank of America Corp · Reduced
Change −195K Date Q1 2026
Bank of America Corp Reduced· Q1 2026 −195K Q1 2026
Schroder Investment Management Group · Reduced
Change −193K Date Q1 2026
Schroder Investment Management Group Reduced· Q1 2026 −193K Q1 2026
Allianz Asset Management GMBH · Added
Change +189K Date Q1 2026
Allianz Asset Management GMBH Added· Q1 2026 +189K Q1 2026
Braidwell LP · Exited
Change −177K Δ Own −100.0% Date Q1 2026
Braidwell LP Exited· Q1 2026 −177K −100.0% Q1 2026
Panagora Asset Management Inc · Added
Change +176K Date Q1 2026
Panagora Asset Management Inc Added· Q1 2026 +176K Q1 2026
Two Sigma Investments, LP · Added
Change +165K Δ Own +196.0% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +165K +196.0% Q1 2026
Campbell & Co Investment Adviser LLC · New
Change +149K Date Q1 2026
Campbell & Co Investment Adviser LLC New· Q1 2026 +149K Q1 2026
Jane Street Group, LLC · Reduced
Change −126K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −126K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 189

Famous investor activity in Castle Biosciences, Inc. (CSTL)

Castle Biosciences, Inc. (CSTL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Maetzold Derek J. · Director 7 operations −$96K
Price $22.92 Qty −4K Owned 12K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Maetzold Derek J. Director 7 operations $22.92 −4K −$96K 12K Jul 14, 2026 Jul 16, 2026
Maetzold Derek J. · Director 2 operations 0
Price $2.39 Owned 85K Trade date Jul 14, 2026 Filed date Jul 16, 2026
Maetzold Derek J. Director 2 operations $2.39 0 85K Jul 14, 2026 Jul 16, 2026
Maetzold Derek J. · Director 7 operations −$239K
Price $24.29 Qty −10K Owned 12K Trade date Jul 1, 2026 Filed date Jul 6, 2026
Maetzold Derek J. Director 7 operations $24.29 −10K −$239K 12K Jul 1, 2026 Jul 6, 2026
Maetzold Derek J. · Director 2 operations 0
Price $2.39 Owned 86K Trade date Jul 1, 2026 Filed date Jul 6, 2026
Maetzold Derek J. Director 2 operations $2.39 0 86K Jul 1, 2026 Jul 6, 2026
Oelschlager Kristen M. · Officer 2 operations −$210K
Price $24.40–$24.78 Qty −9K Owned 22K ΔOwn −28.2% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Oelschlager Kristen M. Officer 2 operations $24.40–$24.78 −9K −$210K 22K −28.2% Jul 1, 2026 Jul 6, 2026
Oelschlager Kristen M. · Officer Sell −$178K
Price $20.71 Qty −9K Owned 30K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Oelschlager Kristen M. Officer Sell $20.71 −9K −$178K 30K Jun 16, 2026 Jun 18, 2026
Maetzold Derek J. · Director 7 operations −$86K
Price $20.66 Qty −4K Owned 13K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Maetzold Derek J. Director 7 operations $20.66 −4K −$86K 13K Jun 15, 2026 Jun 17, 2026
Maetzold Derek J. · Director 2 operations 0
Price $2.39 Owned 92K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Maetzold Derek J. Director 2 operations $2.39 0 92K Jun 15, 2026 Jun 17, 2026
Maetzold Derek J. · Director 7 operations −$205K
Price $20.86 Qty −10K Owned 2K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Maetzold Derek J. Director 7 operations $20.86 −10K −$205K 2K Jun 1, 2026 Jun 3, 2026
Maetzold Derek J. · Director 4 operations 0
Price $2.39 Owned 92K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Maetzold Derek J. Director 4 operations $2.39 0 92K Jun 1, 2026 Jun 3, 2026
Olson Tiffany · Director Grant (A) 12K
Owned 12K Trade date May 28, 2026 Filed date Jun 1, 2026
Olson Tiffany Director Grant (A) 12K 12K May 28, 2026 Jun 1, 2026
Goldberg Ellen · Director Grant (A) 12K
Owned 12K Trade date May 28, 2026 Filed date Jun 1, 2026
Goldberg Ellen Director Grant (A) 12K 12K May 28, 2026 Jun 1, 2026
Harrison Miles · Director Grant (A) 12K
Owned 12K Trade date May 28, 2026 Filed date Jun 1, 2026
Harrison Miles Director Grant (A) 12K 12K May 28, 2026 Jun 1, 2026
Cotton Rodney · Director Grant (A) 12K
Owned 12K Trade date May 28, 2026 Filed date Jun 1, 2026
Cotton Rodney Director Grant (A) 12K 12K May 28, 2026 Jun 1, 2026
Caple Kim · Director Grant (A) 12K
Owned 12K Trade date May 28, 2026 Filed date Jun 1, 2026
Caple Kim Director Grant (A) 12K 12K May 28, 2026 Jun 1, 2026
15 of 84
15 of 84 Sign in to continue to older insider transactions.

Castle Biosciences, Inc. (CSTL) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 3.0M
% of shares outstanding 11.0% Filing date Jul 8, 2024
BlackRock Inc. 3.0M 11.0% Jul 8, 2024
Rtw Investments, LP 2.8M
% of shares outstanding 9.3% Filing date May 15, 2026
Rtw Investments, LP 2.8M 9.3% May 15, 2026
Wasatch Advisors LP
% of shares outstanding 6.6% Filing date Nov 13, 2024
Wasatch Advisors LP 6.6% Nov 13, 2024
Vanguard Group Inc 1.5M
% of shares outstanding 5.4% Filing date Feb 13, 2024
Vanguard Group Inc 1.5M 5.4% Feb 13, 2024
Portolan Capital Management, LLC 1.4M
% of shares outstanding 4.5% Filing date May 15, 2026
Portolan Capital Management, LLC 1.4M 4.5% May 15, 2026
Maetzold Derek J 1.0M
% of shares outstanding 4.0% Filing date Feb 11, 2022
Maetzold Derek J 1.0M 4.0% Feb 11, 2022
Granahan Investment Management, LLC 425K
% of shares outstanding 1.5% Filing date Nov 14, 2024
Granahan Investment Management, LLC 425K 1.5% Nov 14, 2024
7 of 7

Castle Biosciences, Inc. (CSTL) ownership FAQ

Who owns CSTL?

189 reporting institutions disclosed CSTL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.